U.S. Media Stock News

Warrior Met Coal (HCC) has come under pressure as investors react to weaker sentiment toward coking coal producers, worries about softer metallurgical coal demand, and tighter decarbonization scrutiny on steelmakers, alongside insider selling and valuation concerns. See our latest analysis for Warrior Met Coal. That sector driven pullback has left Warrior Met Coal’s share price with a 7 day share price return of 6.9% and a 90 day share price return decline of 11.8%, even though the 1 year...

Recent attention on Sidus Space (SIDU) stems from its 2025 Form 10-K. The company reported lower revenue of US$3.38 million, a net loss of US$29.47 million, and a delayed 10-K filing announcement. See our latest analysis for Sidus Space. Against the backdrop of weaker 2025 results and the delayed 10-K, Sidus Space’s share price has been highly volatile, with a 104.33% 30 day share price return and a 207.97% 1 year total shareholder return, even as the year to date share price return remains...

Fannie Mae has recently begun offering mortgage loans backed by Bitcoin, allowing borrowers to pledge their cryptocurrency as collateral without facing margin calls if Bitcoin’s price falls. This move effectively links a major piece of the U.S. housing finance system to digital assets, potentially reshaping how younger, crypto-rich households access homeownership financing. Next, we’ll explore how Fannie Mae’s Bitcoin-backed mortgages, especially the absence of margin calls, could influence...

Earlier this month, the Ultra Accelerator Link (UALink) Consortium ratified new open specifications adding in-network compute, chiplet integration and centralized manageability to improve large-scale AI accelerator connectivity, with AMD involved through this multi-vendor standards effort. By making all UALink specifications publicly available and fully compliant with UCIe 3.0, the consortium is aiming to reduce vendor lock-in and simplify the design of interoperable AI systems built on...

At the 38th Annual Roth Conference, Amprius Technologies outlined its move toward outsourced manufacturing while highlighting advances in its silicon anode battery technology and operational goals. Beyond operational updates, the company’s focus on eVTOL applications and potential opportunities with large customers underscored how specific use cases are shaping its growth ambitions. We’ll now examine how Amprius’ pivot to outsourced manufacturing could influence its existing investment...

Fortinet (FTNT) is under pressure after public disclosures of a critical FortiClient Endpoint Management Server vulnerability, now on key exploited lists, coincided with sector jitters about AI driven zero day discovery tools. See our latest analysis for Fortinet. The share price reaction to the vulnerability disclosures and AI driven threat concerns has come on top of weaker recent momentum, with a 1 day share price return of 4.91% decline and a 1 year total shareholder return of 21.52%...

J.B. Hunt Transport Services (JBHT) is in focus after a 4.61% premarket move tied to broader market positioning ahead of key inflation data, with investors also watching its growing involvement in electric freight infrastructure. See our latest analysis for J.B. Hunt Transport Services. That premarket jump fits into a stronger trend, with a 30 day share price return of 13.38% and a year to date share price return of 15.38%. The 1 year total shareholder return of 72.74% and 3 year total...

Lam Research (LRCX) is back in focus after fiscal Q2 2026 results outpaced expectations on both revenue and operating income, supported by strong AI driven demand for chip making equipment. See our latest analysis for Lam Research. The share price has surged recently, with a 7 day share price return of 20.70% and a year to date share price return of 42.47%. The 1 year total shareholder return is very large, signalling strong momentum following earnings beats, all time highs, leadership...

Why Zai Lab’s latest lung cancer collaboration matters for shareholders Zai Lab (ZLAB) has drawn fresh attention after reporting ongoing progress in its Phase 3 DLLEVATE trial for ZL-1310 in small cell lung cancer and unveiling a new global clinical collaboration with Amgen. See our latest analysis for Zai Lab. Recent updates around the DLLEVATE trial and the Amgen tie up come after a 30 day share price return of 12.57% and a year to date share price return of 19.33%. This is set against a 1...

CoreWeave (CRWV) stock is back in focus after two long-term AI infrastructure deals: a US$21b expansion with Meta Platforms and a multi-year partnership with Anthropic to support Claude model development and deployment. See our latest analysis for CoreWeave. The latest AI deals have arrived alongside a sharp swing in sentiment, with a 1-day share price return of 10.87%, a 7-day share price return of 24.03%, and a 1-year total shareholder return of 133.14%. This points to strong momentum after...

Earnings and capital moves put Applied Industrial Technologies (AIT) in focus Applied Industrial Technologies (AIT) has drawn fresh attention after reporting quarterly revenue of $1.16b, an 8.4% year on year increase that came in slightly below analyst forecasts, alongside several capital allocation updates. See our latest analysis for Applied Industrial Technologies. The quarterly update, together with an 11% dividend increase, a bolt on acquisition of Thompson Industrial Supply Inc., and...

In recent days, Quest Diagnostics, which processes lab tests for roughly one-third of U.S. adults each year, has faced renewed scrutiny as rising operating expenses have weighed on its adjusted operating margin and highlighted the limits of scale-driven growth versus smaller rivals. Fresh concerns about valuation, underscored by insider share sales of about US$12.80 million over three months and external models flagging limited margin of safety, have sharpened investor focus on how much...

With energy driven inflation, geopolitical tensions and AI related demand all feeding into higher input costs, investors are paying closer attention to the raw materials that keep the global economy running. Copper sits at the center of that story, and the current structural supply strain makes careful stock selection more important than ever. The Top Copper Stocks screener filters for producers with stronger balance sheets and lower production costs so that you can focus on businesses that...

Event driven snapshot of AerCap Holdings (AER) AerCap Holdings (AER) has come into focus after a recent move in its share price, with the stock closing at US$145.53 and reporting double digit total returns over the past year and over the past 3 months. See our latest analysis for AerCap Holdings. The recent 7 day share price return of 4.56% and 30 day share price return of 9.39% sit alongside a 1 year total shareholder return of 59.72%. This suggests momentum has been building over both...

Wondering if Coterra Energy at around US$33.41 is offering real value or just tracking the wider market noise? This article breaks down what the current price might be telling you. The stock has seen a 3.3% decline over the last 7 days, a 3.9% gain over the last 30 days, and returns of 25.6% year to date and 37.3% over the past 12 months, which suggests sentiment around the shares has shifted over different time frames. Recent attention on Coterra Energy has centered on its role within the...

Investor attention on Kinsale Capital Group (KNSL) is building ahead of its April 23 earnings release, with projections calling for a 26.68% year over year EPS increase and reflecting interest in the insurer’s growth profile. See our latest analysis for Kinsale Capital Group. Despite optimistic earnings expectations, Kinsale’s recent share price performance has cooled, with a 90 day share price return of 10.77% and a 1 year total shareholder return of 27.65% decline, while the 5 year total...

What recent returns tell you about Cboe Global Markets (CBOE) Cboe Global Markets (CBOE) has drawn fresh attention after a period of solid share price gains, with the stock showing positive returns over the past week, month, past 3 months and year. Over the past week the stock returned 2.1%, with a similar 2.1% move over the past month. The past 3 months show a 12.1% return, while the 1 year total return stands at 39.1%. In the longer term, Cboe’s total return is 124.4% over 3 years and...

In recent days, GPGI has seen optimism cool as analysts’ previous enthusiasm collided with concerns about sharply declining revenue growth and weak fundamentals, even as retail traders stayed active. The contrast between a bullish analyst rating and limited institutional participation suggests that professional investors remain cautious about the company’s underlying business strength. We’ll now examine how this skepticism toward the bullish rating, despite solid retail interest, reshapes...

Intuitive Surgical (ISRG) has moved back into focus after large hedge funds sharply increased their positions, as the company reported strong procedure volumes, recurring revenue strength, and the ongoing rollout of its da Vinci 5 system. See our latest analysis for Intuitive Surgical. The latest share price of US$450.62 leaves Intuitive Surgical with a 30 day share price return of a 4.56% decline and a year to date share price return of a 19.82% decline. The 3 year total shareholder return...

In early April 2026, Unrivaled Sports announced landmark partnerships with Under Armour and DICK'S Sporting Goods, naming Under Armour the exclusive performance apparel partner for Ripken Nationals and several other major youth baseball and flag football events nationwide. This move embeds Under Armour directly into high-profile youth sports experiences, potentially reinforcing its brand with young athletes and their families at key moments of engagement. We’ll now look at how becoming the...

In recent days, Ecolab has drawn attention as analysts pointed to its history of earnings coming in above forecasts and anticipated a further profit increase ahead of its late-April 2026 quarterly report. At the same time, the company has been riding improving sentiment around innovation in water treatment technologies, which is lifting expectations even without fresh company-specific announcements. With this backdrop of recent earnings outperformance and sector momentum, we will now examine...

Event context and recent share performance Rhythm Pharmaceuticals (RYTM) has drawn investor attention after recent trading, with the stock closing at US$84.39 and showing a 2% decline over the past day and a 19.5% decline over the past 3 months. See our latest analysis for Rhythm Pharmaceuticals. The recent 3 month share price return of negative 19.5% contrasts with a 1 year total shareholder return of 41.7% and a 3 year total shareholder return around 4.4x. This suggests short term momentum...

Eli Lilly (NYSE:LLY) is seeing rapid market share declines in India for its GLP-1 obesity drugs as generic competitors expand following patent expirations. At the same time, Lilly is rolling out its new oral obesity pill Foundayo in the U.S. through online pharmacies, retail chains, and telehealth platforms. Foundayo is now available via Amazon Pharmacy, GoodRx, Ro, LifeMD, and major retail pharmacies, with both self pay and insured options for American patients. The combination of pressure...

If you are wondering whether Phibro Animal Health's share price still makes sense after a big run, this article walks through what that current price might imply about value. The stock last closed at US$57.89, with returns of 4.3% over 7 days, 17.0% over 30 days, 55.2% year to date and 235.2% over the past year. Recent coverage has focused on Phibro Animal Health as part of broader discussions around animal health companies and how investors are reassessing risks and business models in this...